CPA
APYX icon

Columbia Pacific Advisors’s Apyx Medical APYX Stock Holding History

Columbia Pacific Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-115,000
Closed -$574K – 23
2018
Q3 		$574K Buy
+115,000
New +$639K 0.79% 22

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HK
Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Columbia Pacific Advisors's APYX Position: Q4 2018 in Review

Columbia Pacific Advisors sold out of Apyx Medical (APYX) in Q4 2018, closing a stake of 115,000 shares — an estimated $574K sold.

Columbia Pacific Advisors first reported a position in APYX in Q3 2018 and held it in 1 quarter. The position peaked at $574K in Q3 2018. 61 funds tracked by Wall St. Rank hold APYX as of Q4 2018.

  • Columbia Pacific Advisors reported no remaining Apyx Medical position as of Q4 2018 after selling out during the quarter.
  • Columbia Pacific Advisors sold 115,000 Apyx Medical shares in Q4 2018, an estimated $574K.
  • Columbia Pacific Advisors first reported a position in Apyx Medical in Q3 2018 and held it in 1 quarter.
  • Columbia Pacific Advisors's Apyx Medical position peaked at $574K in Q3 2018.
  • 61 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2018.

Based on Columbia Pacific Advisors's 13F filing for Q4 2018, filed 8 Feb 2019.